摘要 |
Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I: wherein R2, R6.ALPHA., R6B and R8 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, synthetic methods, and intermediates are also disclosed.
|
申请人 |
PFIZER PRODUCTS INC. |
发明人 |
HUGHES, ROBERT O.;BELL, ANDREW SIMON;BROWN, DAVID GRAHAM;OWEN, DAFYDD RHYS;PALMER, MICHAEL JOHN;PHILLIPS, CHRISTOPHER;BROWN, DAVID LOUIS;FOBIAN, YVETTE MARLENE;FRESKOS, JOHN NICHOLAS;HEASLEY, STEVEN EDWARD;JACOBSEN, ERIC JON;MADDUX, TODD MICHAEL;MISCHKE, BRENT VIRGIL;MOLYNEAUX, JOHN MAJOR;MOON, JOSEPH BLAIR;ROGIER, DONALD JOSEPH, JR.;TOLLEFSON, MICHAEL BRENT;WALKER, JOHN KEITH |